InvestorsHub Logo

kiy

03/27/14 2:00 PM

#10788 RE: kiy #10765

ATRX

(I'm looking for a place in this one...
Arotech is significantly undervalued despite being a small and growing firm with promising future bullish catalysts.
ARTX offers solid fundamentals, highlighted by the Piotroski F-Score, that are rarely seen with companies comparable to it.
Taking all into consideration we believe that ARTX is currently undervalued by 50% and are setting a short-term price target of $7.85.